E-LIB Suche - Ergebnisse für: Nikfar S

1

PCV8 Cost-Utility and Budget IMPACT Analysis of Using Ranol..:

Zargaran, M. ; Nikfar, S. ; Ghanavati, R..
Value in Health Regional Issues. 22 (2020) - p. S27 , 2020

Link: https://doi.org/10.1016/..

2

PND45 OCRELIZUMAB IS A COST-EFFECTIVE OPTION FOR RELAPSING ..:

Ayati, N. ; Sahraian, M.A. ; Taheri, S..
Value in Health. 22 (2019) - p. S744-S745 , 2019

Link: https://doi.org/10.1016/..

3

PPM2 A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS FOR PHARMA..:

Nosrati, M. ; Mozafari, S. ; Nikfar, S...
Value in Health. 22 (2019) - p. S837 , 2019

Link: https://doi.org/10.1016/..

4

PND47 CLADRIBINE TABLET, AS A DOMINANT COMPARATOR TO NATALI..:

Ayati, N. ; Fleifel, L. ; Sharifi, S...
Value in Health. 22 (2019) - p. S745 , 2019

Link: https://doi.org/10.1016/..

5

PHP201 - DEVELOPMENT OF MEDICATION SAFETY STANDARDS IN SELE..:

Izadpanah, F. ; Nikfar, S. ; Bakhshi Imcheh, F..
Value in Health. 21 (2018) - p. S184 , 2018

Link: https://doi.org/10.1016/..

6

Comparison of the Cost-utility Analysis of Electroacupunctu..:

Ayati, M.H. ; Toroski, M. ; Nikfar, S...
Journal of Acupuncture and Meridian Studies. 11 (2018) 4 - p. 182-183 , 2018

Link: https://doi.org/10.1016/..

7

PIN49 - THE COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN VE..:

Afzali, M. ; Zartab, S. ; Zaboli, P...
Value in Health. 21 (2018) - p. S229 , 2018

Link: https://doi.org/10.1016/..

8

Cost Utility Analysis of Infliixmab and Adalimumab Compared..:

Zaboli, P ; Nikfar, S ; Kebriaeezadeh, A...
Value in Health. 20 (2017) 9 - p. A636 , 2017

Link: https://doi.org/10.1016/..

9

Evaluation of Health Care Reform Impact on Cancer Patients`..:

Sarkhanloo, F ; Zaboli, P ; Saeedi, M...
Value in Health. 20 (2017) 9 - p. A880 , 2017

Link: https://doi.org/10.1016/..

10

Providing A Framework For Assessing Access To Medicine:

Afzali, M ; Nikfar, S ; Alvandi, M...
Value in Health. 20 (2017) 9 - p. A658 , 2017

Link: https://doi.org/10.1016/..

11

Evaluation of Health Care Reform Impact on Cancer Patients`..:

Mansoori, M ; Zaboli, P ; Saeedi, M...
Value in Health. 20 (2017) 9 - p. A879 , 2017

Link: https://doi.org/10.1016/..

12

The Impress Of Pharmacoeconomics In Pricing Decisions In IF..:

Ghiasi, G ; Nikfar, S
Value in Health. 20 (2017) 9 - p. A465 , 2017

Link: https://doi.org/10.1016/..

13

Therapeutic effects of oral liothyronine on aluminum phosph..:

Goharbari, MH ; Taghaddosinejad, F ; Arefi, M...
Human & Experimental Toxicology. 37 (2017) 2 - p. 107-117 , 2017

Link: https://doi.org/10.1177/..

14

A Cost Minimization Analysis of Azelastine/Fluticasone Comb..:

Zaboli, P ; Nikfar, S ; Ayati, N...
Value in Health. 20 (2017) 9 - p. A647 , 2017

Link: https://doi.org/10.1016/..

15

Cost Utility Analysis of Single Fraction Versus Multiple Fr..:

Bayazidi, Y ; Keshtkaran, A ; Homaie Rad, E...
Value in Health. 20 (2017) 9 - p. A445 , 2017

Link: https://doi.org/10.1016/..